Relationships between hourly cognitive variability and risk of Alzheimer’s disease revealed with mixed-effects location scale models.
Neuropsychology · 2024
DOI: 10.1037/neu0000905 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychology, 2024. Verfasst von Andrew J Aschenbrenner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, School of Medicine, Washington University in St. Louis. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 28-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, School of Medicine, Washington University in St. Louis.
- Department of Psychiatry, School of Medicine, Washington University in St. Louis.
- Department of Psychological and Brain Sciences, Washington University in St. Louis.
ORCID-Profile: Andrew J Aschenbrenner, John C Morris
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Aschenbrenner, A. J., Hassenstab, J., Morris, J. C., Cruchaga, C., & Jackson, J. J. (2024). Relationships between hourly cognitive variability and risk of Alzheimer’s disease revealed with mixed-effects location scale models. Neuropsychology. https://doi.org/10.1037/neu0000905
Vancouver
Aschenbrenner AJ, Hassenstab J, Morris JC, Cruchaga C, Jackson JJ. Relationships between hourly cognitive variability and risk of Alzheimer’s disease revealed with mixed-effects location scale models. Neuropsychology. 2024. doi:10.1037/neu0000905
BibTeX
@article{Aschenbrenner2024,
author = {Aschenbrenner, Andrew J and Hassenstab, Jason and Morris, John C and Cruchaga, Carlos and Jackson, Joshua J},
title = {Relationships between hourly cognitive variability and risk of Alzheimer’s disease revealed with mixed-effects location scale models},
journal = {Neuropsychology},
year = {2024},
doi = {10.1037/neu0000905}
}
EUVIMED